Financials
Financial year 2025
Favresse Diagnostics from Ramillies, company number BE0760571951, closed financial year 2025 with a result of € 302,908 after tax. For that financial year Favresse Diagnostics recorded a gross margin of € 413,115 and equity of € 1,655. Compared with financial year 2024, the result moved from € 237,481 to € 302,908. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 1,655
▲ 50% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 302,908
▲ 28% vs 2024
Profit after tax over the fiscal year.
€ 236,294
▼ 31% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 302,355 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 1,752
▼ 27% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 43,025
▼ 32% vs 2024
€ 22,268 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 2,006
▲ € 1,686 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 19,431
▼ 17% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 121,113 | € 259,824 | € 325,385 | € 413,115 | ▲ 27% |
| Profit after taxes | € 76,936 | € 181,998 | € 237,481 | € 302,908 | ▲ 28% |
| Equity | € 139,198 | € 256,545 | € 1,102 | € 1,655 | ▲ 50% |
| Total debts | € 146,910 | € 207,971 | € 580,443 | € 417,051 | ▼ 28% |
| Cash | € 113,943 | € 277,855 | € 343,827 | € 236,294 | ▼ 31% |
| Retained profit | € 138,198 | € 255,545 | € 102 | € 655 | ▲ € 553 |
| Dividend | € 800 | € 64,651 | € 492,924 | € 302,355 | ▼ 39% |
| Bank debt | € 103,520 | € 83,544 | € 63,380 | € 43,025 | ▼ 32% |
| Balance sheet total | € 286,108 | € 464,517 | € 581,546 | € 418,707 | ▼ 28% |
Key figures of Favresse Diagnostics, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Favresse Diagnostics?
What happened at Favresse Diagnostics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 302,908 (▲ 28% vs 2024). Source: NBB ↗
- New establishment in Namur. KBO
- Julien FAVRESSE became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 76,936 profit in 2022 to € 302,908 profit in 2025.
Paid € 240,927 in corporate taxes since 2022.
Best year ever: 2025, with € 302,908 profit.
Paid out € 860,730 in dividends to the owners in total.
Management
Behind Favresse Diagnostics is Julien FAVRESSE.
Directors
According to the 2025 annual accounts
Julien FAVRESSE
Director
since 2021
Establishments
Establishment units
Physical locations of this company
Rue Petite Coyarde 38
1367 Ramillies
Rue Saint-Luc(BU) 8
5004 Namur
Active since 1 January 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0760.571.951
- VAT number
- BE 0760.571.951
- Registered office
- Rue Petite Coyarde 38, 1367 Ramillies
- Names & denominations
- Favresse Diagnostics
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 December 2020
- Peppol
- Active · Active since 7 Jan 2026
- Contact
- [email protected] +32479020590